The identification of a functional erm(41) gene in Mycobacterium abscessus isolates has called into question the clinical usefulness of macrolides in the treatment of these infections [7,15,16], although the CLSI suggests inclusion of macrolides in the case of inducible resistance due to a lack of sufficient alternate options, and emperical evidence showing some usefulness. The gene discussed is ETV5; the disease is infection.